Artivion
Artivion is a prominent medical device company specializing in the development and manufacture of implantable biological devices and surgical adhesives aimed at cardiac and vascular reconstruction. The company focuses on providing a range of aortic-centric solutions for cardiac and vascular surgeons, which includes products such as aortic and mitral heart valves, aortic allografts, pulmonary human heart valves, and pulmonary patches. Additionally, Artivion produces various surgical adhesives and sealants designed to enhance surgical outcomes. The company is also known for its SynerGraft technology, which is utilized in processing human tissues, including proprietary products like the CryoValve SG pulmonary heart valve and CryoPatch SG pulmonary cardiac patch. Through its innovative offerings, Artivion aims to improve the quality of care for patients undergoing cardiac and vascular procedures.
Ascyrus Medical is a medical device company that offers a proprietary technology designed to decrease the complications and complexity associated with Type A aortic dissections. The technology helps in reducing the immediate and long-term impact of the disease. The company was founded in January 2015 by cardiac surgeon Ali Shahriari, MD.
JOTEC develops, produces, and markets medical devices for aortic and peripheral vascular disease. JOTEC’s product portfolio encompasses conventional vascular grafts and interventional implants for vascular and cardiac surgery and radiology and cardiology.
On-X Life Technologies develops, manufactures, and offers artificial heart valve replacement and repair products. The company’s product portfolio includes Aortic Heart Valve with Standard Sewing Ring, Aortic Heart Valve with Conform-X Sewing Ring, Aortic Heart Valve with Anatomic Sewing Ring, Mitral Heart Valve with Standard Sewing Ring, Mitral Heart Valve with Conform-X Sewing Ring, Ascending Aortic Prosthesis, Chord-XTM ePTFE Suture, CO2 diffusion catheters, and more. On-X Life Technologies was incorporated in 1994 and is based in Austin, Texas.
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction.
ValveXchange, Inc. develops two-part bioprosthetic tissue valves that resolve the compromises between conventional mechanical and tissue heart valves. It offers Vitality exchangeable heart valve systems; Vitality exchangeable tissue valves; valve delivery and exchange systems; transapical implants and exchanges; and apical introducers. ValveXchange is based in Aurora, Colorado.
Cardiogenesis Corporation
Acquisition in 2011
Cardiogenesis Corporation designs, develops, and distributes laser-based surgical products and disposable fiber-optic accessories for the treatment of cardiac ischemia associated with advanced cardiovascular disease. The company offers minimally-invasive transmyocardial revascularization fiberoptic delivery, robotic hand piece delivery, and complete console and cardiovascular delivery systems. Additionally, Cardiogenesis provides reimbursement services. Cardiogenesis pioneered the development of Transmyocardial revascularization (TMR) procedures, a method of therapy and treatment for refractive angina that is approved by the American College of Cardiology, American Heart Association, and the Society of Thoracic Surgery. Cardiogenesis was founded in 1989 and is headquartered in Kennesaw, Georgia. As of May 17, 2011, Cardiogenesis Corporation operates as a subsidiary of CryoLife Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.